IV Infusion/Bolus Pk normalisation [Dissolution / BCS / IVIVC]

posted by msmnainar – India, 2021-06-24 07:11 (219 d 07:34 ago) – Posting: # 22431
Views: 631

» How to fit pk parameters derived from IV lower strength data with ER/IR/MR/DR higher strength oral formulation data? What are the pk parameters needs to focus?


Usually AUC is the parameter you can compare, if you are looking to generate absolute bioavailability details. However, your dose selection depends upon the bioavailability of extravascular administration.

However, I dont understand the selection of IV lower strength and oral higher strength. Do you have any correlation on data?

Sundar. M

Complete thread:

 Admin contact
21,858 posts in 4,574 threads, 1,554 registered users;
online 15 (0 registered, 15 guests [including 13 identified bots]).
Forum time: Saturday 13:45 CET (Europe/Vienna)

Truth in science can be defined as the working hypothesis best suited
to open the way to the next better one.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz